Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with norwalk virus

58Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A hemagglutination inhibition (HAI) assay to assess serum antibody responses following Norwalk virus (NV) infection was developed. HAI activity increased significantly in individuals experimentally infected with NV (n = 18) and correlated with antibody levels measured in a histo-blood group antigen (HBGA) blocking assay. Prechallenge HAI antibody levels also correlated with protection from the development of gastroenteritis (Mann-Whitney test, P = 0.02). The HAI assay is another assay suitable for the detection of antibody that correlates with protection from Norwalk virus-associated disease. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Czakó, R., Atmar, R. L., Opekun, A. R., Gilger, M. A., Graham, D. Y., & Estesa, M. K. (2012). Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with norwalk virus. Clinical and Vaccine Immunology, 19(2), 284–287. https://doi.org/10.1128/CVI.05592-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free